Doxazosin Tablet
Product Images NDC 66267-377

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 66267-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

66267 377 30

66267 377 30
This is a description of a medicine package. The medicine is Doxazosin 4mg in the form of 30 scored, round, cream-yellow tablets. The lot number is 000000, and the expiry is 00-00. The manufacturer's NDC is 16729-213-01, while the National Drug Code is 66267-0377-30, and the GTIN is 00366267377300. The patient is advised to refrain from handing the medication to children to avoid possible side effects. The package should be stored between 59-86°F.*
FDA Label Image

Table 1 (Doxazosin Fig1)

Table 1 (Doxazosin Fig1)
The text appears to be a table summarizing effectiveness data in placebo-controlled trials. The table includes data on maximum flow rate, symptom score, and rate of change for various doses of doxazosin and placebo in three different studies. The AUA questionnaire and Modified Boyarsky Questionnaire were used to measure symptom scores across the different studies. The text also includes additional notes on the dosage and efficacy phases in the studies.*
FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Figure 1 – Study 1 (Doxazosin Fig2)
This text appears to be a table showing mean changes in maximum urinary flow rate (mUsec) and total symptom score from baseline, with comparison to a placebo group and to baseline. The table also includes the duration of treatment (in weeks) and a note about doxazosin titration to a maximum of 8 mg. There is also a notation indicating statistical significance for the comparison to placebo and to baseline.*
FDA Label Image

Chemical Structure (Doxazosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.